DTOX - CITA BIOMEDICAL, ULTRA RAPID OPIATE DETOXIFICATION Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DTOX - CITA BIOMEDICAL, ULTRA RAPID OPIATE DETOXIFICATION

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Buck who wrote (23)	2/17/1999 3:56:00 AM
From: Cisco	Read Replies (1) of 96

Consider the following numbers: If CITA ends up getting 1% of the 810,000 heroin addicts in the US in their centers that would be 8,100 patient per year. At $3,000 gross per patient that would be revenues of $24,3000,000. Apply a 30 times earnings to this number and divide by the outstanding number of shares and we will have a very attractive share price. I understand that 30 times earnings is a fair evaluation for this type of company. I am not exactly sure what the net earnings would be, but I was told by PR that if each of the first 4 centers did only 10 patients per month, 2,080 patients per year, that that would translate based on 30 times earnings to a $5 share price. With 3 centers opened, 3 centers close to being open, and 10 expected by year end, one would expect CITA to have a shot at the 1% within a couple of years. Based upon the above information that would be equal to a share price of around $19. Personaly, I would be happy with $5 within the next 18 months. Wouldn't it be nice, if their press releases mention their potential market!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next